After Paper Shakes Sector, Gene Therapy Leader Jim Wilson Talks Safety – Xconomy
Xconomy |
After Paper Shakes Sector, Gene Therapy Leader Jim Wilson Talks Safety
Xconomy Gene therapy pioneer James Wilson and University of Pennsylvania colleagues sounded an alarm Tuesday morning about the use of gene therapy to treat severe diseases like spinal muscular atrophy and Duchenne muscular dystrophy, sending a chill across the … Gene therapy stocks slammed after scientist reveals safety concerns … Scholarly Article Proves Toxic to Gene–Therapy Stocks New study shows severe toxicity with high-dose AAV9-based gene therapy in animal models |
